MSB 2.10% $1.17 mesoblast limited

Terrible if realized. Yes. Investing in biotech sucks doesn't...

  1. 1,896 Posts.
    lightbulb Created with Sketch. 490
    Terrible if realized. Yes. Investing in biotech sucks doesn't it? Except for when it doesn't. You're pretending like it's low risk, high reward.

    You saw that we partnered with BMT, who is funded by the NIH, & thought - "Yup, no sign". Experts in the US are highlighting it's potential and your argument was to immediately looked backwards.

    You said "no sign" literally as there's was a sign. Despite all your other ramblings - you were objectively wrong.
    Last edited by pld89: 23/11/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.324B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 1335 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.